메뉴 건너뛰기




Volumn 7, Issue 2, 2015, Pages 189-203

Antiviral treatment for chronic hepatitis B in renal transplant patients

Author keywords

Entecavir; Hepatitis B; Long term outcome; Renal transplantation; Tenofovir

Indexed keywords


EID: 84922418728     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i2.189     Document Type: Review
Times cited : (15)

References (87)
  • 1
    • 0036899604 scopus 로고    scopus 로고
    • Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001
    • [PMID: 12454235]
    • McDonald SP, Russ GR. Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001. Nephrol Dial Transplant 2002; 17: 2212-2219 [PMID: 12454235 DOI: 10.1093/ndt/17.12.2212]
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 2212-2219
    • McDonald, S.P.1    Russ, G.R.2
  • 2
    • 0037148938 scopus 로고    scopus 로고
    • Strategies to improve long-term outcomes after renal transplantation
    • [PMID:11856798]
    • Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-590 [PMID:11856798 DOI: 10.1056/NEJMra011295]
    • (2002) N Engl J Med , vol.346 , pp. 580-590
    • Pascual, M.1    Theruvath, T.2    Kawai, T.3    Tolkoff-Rubin, N.4    Cosimi, A.B.5
  • 6
    • 33751211857 scopus 로고    scopus 로고
    • Management of hepatitis B and C virus infection before and after renal transplantation
    • Fabrizi F, Martin P. Management of hepatitis B and C virus infection before and after renal transplantation. Curr Opin Organ Transplant 2006; 11: 583-588 [DOI: 10.1097/MOT.0b013e3280105c5c]
    • (2006) Curr Opin Organ Transplant , vol.11 , pp. 583-588
    • Fabrizi, F.1    Martin, P.2
  • 8
    • 84861821803 scopus 로고    scopus 로고
    • Viral hepatitis infections in chronic kidney disease patients and renal transplant recipients
    • [PMID: 22677941]
    • Urbánek P. Viral hepatitis infections in chronic kidney disease patients and renal transplant recipients. Kidney Blood Press Res 2012; 35: 454-467 [PMID: 22677941 DOI: 10.1159/000338309]
    • (2012) Kidney Blood Press Res , vol.35 , pp. 454-467
    • Urbánek, P.1
  • 9
    • 70349240414 scopus 로고    scopus 로고
    • Chronic hepatitis B: update 2009
    • [PMID: 19714720]
    • Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-662 [PMID: 19714720 DOI: 10.1002/hep.23190]
    • (2009) Hepatology , vol.50 , pp. 661-662
    • Lok, A.S.1    McMahon, B.J.2
  • 10
    • 84862664371 scopus 로고    scopus 로고
    • EASL clinical practice guidelines: Management of chronic hepatitis B virus infection
    • [PMID: 22436845]
    • European Association for the Study of the Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167-185 [PMID: 22436845 DOI: 10.1016/j.jhep.2012.02.010]
    • (2012) J Hepatol , vol.57 , pp. 167-185
  • 11
    • 84889687049 scopus 로고    scopus 로고
    • Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease
    • [PMID: 24299322]
    • Pipili C, Cholongitas E, Papatheodoridis G. Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease. Aliment Pharmacol Ther 2014; 39: 35-46 [PMID: 24299322 DOI: 10.1111/apt.12538]
    • (2014) Aliment Pharmacol Ther , vol.39 , pp. 35-46
    • Pipili, C.1    Cholongitas, E.2    Papatheodoridis, G.3
  • 13
    • 80051820339 scopus 로고    scopus 로고
    • Hepatic venous pressure gradient and transjugular liver biopsy to assess patients with kidney failure and chronic liver disease
    • [PMID: 21738254]
    • García Agudo R, Aoufi Rabih S, Pérez Roldán F, Guzmán Ames F, González Carro P, Ruiz Carrillo F, Cuesta Domínguez R. Hepatic venous pressure gradient and transjugular liver biopsy to assess patients with kidney failure and chronic liver disease. Nefrologia 2011; 31: 490-492 [PMID: 21738254 DOI: 10.3265/Nefrologia. pre2011.May.10878]
    • (2011) Nefrologia , vol.31 , pp. 490-492
    • García Agudo, R.1    Aoufi Rabih, S.2    Pérez Roldán, F.3    Guzmán Ames, F.4    González Carro, P.5    Ruiz Carrillo, F.6    Cuesta Domínguez, R.7
  • 14
    • 60749126501 scopus 로고    scopus 로고
    • KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease
    • [PMID: 18382440]
    • Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl 2008; 73 (Suppl 109): S1-99 [PMID: 18382440 DOI: 10.1038/ki.2008.81]
    • (2008) Kidney Int Suppl , vol.73 , pp. S1-S99
  • 15
    • 74949094555 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for the care of kidney transplant recipients
    • [PMID:19845597]
    • Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9 Suppl 3: S1-155 [PMID:19845597 DOI: 10.1111/j.1600-6143.2009.02834.x]
    • (2009) Am J Transplant , vol.9 , pp. S1-S155
  • 16
    • 64249155171 scopus 로고    scopus 로고
    • Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis
    • [PMID: 19196449]
    • Alric L, Kamar N, Bonnet D, Danjoux M, Abravanel F, Lauwers-Cances V, Rostaing L. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis. Transpl Int 2009; 22: 568-573 [PMID: 19196449 DOI: 10.1111/j.1432-2277.2009.00834.x]
    • (2009) Transpl Int , vol.22 , pp. 568-573
    • Alric, L.1    Kamar, N.2    Bonnet, D.3    Danjoux, M.4    Abravanel, F.5    Lauwers-Cances, V.6    Rostaing, L.7
  • 17
    • 84922042335 scopus 로고    scopus 로고
    • Effect of Prophylactic Versus Preemptive Lamivudine Treatment and Tenofovir on HBsAg (+) Kidney Transplant Recipients
    • Jun 25, Epub ahead of print [PMID:25019317]
    • Ruhi C, Süleymanlar I, Koçak H, Dinçkan A, Ersoy F, Süleymanlar G. Effect of Prophylactic Versus Preemptive Lamivudine Treatment and Tenofovir on HBsAg (+) Kidney Transplant Recipients. Exp Clin Transplant 2014 Jun 25; Epub ahead of print [PMID:25019317 DOI: 10.6002/ect.2013.0280]
    • (2014) Exp Clin Transplant
    • Ruhi, C.1    Süleymanlar, I.2    Koçak, H.3    Dinçkan, A.4    Ersoy, F.5    Süleymanlar, G.6
  • 18
    • 11844299575 scopus 로고    scopus 로고
    • HBV reactivation after kidney transplantation
    • [PMID: 15653420]
    • Berger A, Preiser W, Kachel HG, Stürmer M, Doerr HW. HBV reactivation after kidney transplantation. J Clin Virol 2005; 32: 162-165 [PMID: 15653420 DOI: 10.1016/j.jcv.2004.10.006]
    • (2005) J Clin Virol , vol.32 , pp. 162-165
    • Berger, A.1    Preiser, W.2    Kachel, H.G.3    Stürmer, M.4    Doerr, H.W.5
  • 19
    • 84866356153 scopus 로고    scopus 로고
    • Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection
    • [PMID: 22921412]
    • Kanaan N, Kabamba B, Maréchal C, Pirson Y, Beguin C, Goffin E, Hassoun Z. Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection. J Clin Virol 2012; 55: 233-238 [PMID: 22921412 DOI: 10.1016/j.jcv.2012.07.015]
    • (2012) J Clin Virol , vol.55 , pp. 233-238
    • Kanaan, N.1    Kabamba, B.2    Maréchal, C.3    Pirson, Y.4    Beguin, C.5    Goffin, E.6    Hassoun, Z.7
  • 21
    • 40849135610 scopus 로고    scopus 로고
    • The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting
    • [PMID: 18203658]
    • Barclay S, Pol S, Mutimer D, Benhamou Y, Mills PR, Hayes PC, Cameron S, Carman W. The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting. J Clin Virol 2008; 41: 243-254 [PMID: 18203658 DOI: 10.1016/j.jcv.2007.11.017]
    • (2008) J Clin Virol , vol.41 , pp. 243-254
    • Barclay, S.1    Pol, S.2    Mutimer, D.3    Benhamou, Y.4    Mills, P.R.5    Hayes, P.C.6    Cameron, S.7    Carman, W.8
  • 22
    • 0037183613 scopus 로고    scopus 로고
    • Management of chronic viral hepatitis before and after renal transplantation
    • [PMID: 12352899]
    • Gane E, Pilmore H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 2002; 74: 427-437 [PMID: 12352899]
    • (2002) Transplantation , vol.74 , pp. 427-437
    • Gane, E.1    Pilmore, H.2
  • 25
    • 85052408257 scopus 로고    scopus 로고
    • NC 27709, USA: GlaxoSmithKline Research Triangle Park
    • Lamivudine (Epivir®) prescribing information. NC 27709, USA: GlaxoSmithKline Research Triangle Park, 2013
    • (2013)
  • 26
    • 85052409750 scopus 로고    scopus 로고
    • Foster City, CA 94404, USA: Gilead Sciences, Inc
    • Adefovir (Hepsera®) prescribing information. Foster City, CA 94404, USA: Gilead Sciences, Inc., 2012
    • (2012)
  • 27
    • 85052409667 scopus 로고    scopus 로고
    • New Jersey 07936, USA: East Hanover
    • Telbivudine (Tyzeka®) Novartis Pharmaceuticals Corporation. New Jersey 07936, USA: East Hanover, 2013
    • (2013)
  • 28
    • 85052411168 scopus 로고    scopus 로고
    • NJ 08543, USA: Princeton
    • Entecavir (Baraclude®) Bristol-Myers Squibb Company. NJ 08543, USA: Princeton, 2014
    • (2014)
  • 29
    • 85052411385 scopus 로고    scopus 로고
    • Foster City, CA 94404, USA: Gilead Sciences, Inc.
    • Tenofovir (Viread®) prescribing information. Foster City, CA 94404, USA: Gilead Sciences, Inc., 2013
    • (2013)
  • 30
    • 1842577541 scopus 로고    scopus 로고
    • Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials
    • [PMID: 15077027]
    • Fabrizi F, Dulai G, Dixit V, Bunnapradist S, Martin P. Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials. Transplantation 2004; 77: 859-864 [PMID: 15077027]
    • (2004) Transplantation , vol.77 , pp. 859-864
    • Fabrizi, F.1    Dulai, G.2    Dixit, V.3    Bunnapradist, S.4    Martin, P.5
  • 31
    • 77955424877 scopus 로고    scopus 로고
    • Longterm outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments
    • [PMID: 20562676]
    • Yap DY, Tang CS, Yung S, Choy BY, Yuen MF, Chan TM. Longterm outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments. Transplantation 2010; 90: 325-330 [PMID: 20562676 DOI: 10.1097/TP.0b013e3181e5b811]
    • (2010) Transplantation , vol.90 , pp. 325-330
    • Yap, D.Y.1    Tang, C.S.2    Yung, S.3    Choy, B.Y.4    Yuen, M.F.5    Chan, T.M.6
  • 33
    • 3042703006 scopus 로고    scopus 로고
    • Prospective study on lamivudine-resistant hepatitis B in renal allograft recipients
    • [PMID: 15196068]
    • Chan TM, Tse KC, Tang CS, Lai KN, Ho SK. Prospective study on lamivudine-resistant hepatitis B in renal allograft recipients. Am J Transplant 2004; 4: 1103-1109 [PMID: 15196068 DOI: 10.1111/j.1600-6143.2004.00467.x]
    • (2004) Am J Transplant , vol.4 , pp. 1103-1109
    • Chan, T.M.1    Tse, K.C.2    Tang, C.S.3    Lai, K.N.4    Ho, S.K.5
  • 35
    • 19044369343 scopus 로고    scopus 로고
    • Treatment with adefovir dipivoxil in a renal transplant patient with renal insufficiency and lamivudine-resistant hepatitis B infection
    • [PMID: 15866639]
    • Garcia A, Mazuecos A, González P, Diaz F, Garcia T, Ceballos M, Rivero M. Treatment with adefovir dipivoxil in a renal transplant patient with renal insufficiency and lamivudine-resistant hepatitis B infection. Transplant Proc 2005; 37: 1462-1463 [PMID: 15866639 DOI: 10.1016/j.transproceed.2005.02.010]
    • (2005) Transplant Proc , vol.37 , pp. 1462-1463
    • Garcia, A.1    Mazuecos, A.2    González, P.3    Diaz, F.4    Garcia, T.5    Ceballos, M.6    Rivero, M.7
  • 36
    • 33750931569 scopus 로고    scopus 로고
    • Treatment of lamivudine-resistant hepatitis B infection in postrenal transplant patients with adefovir dipivoxil: preliminary results
    • [PMID: 17112914]
    • de Silva HJ, Dassanayake AS, Manamperi A, de Silva AP. Treatment of lamivudine-resistant hepatitis B infection in postrenal transplant patients with adefovir dipivoxil: preliminary results. Transplant Proc 2006; 38: 3118-3120 [PMID: 17112914 DOI: 10.1016/j.transproceed.2006.08.186]
    • (2006) Transplant Proc , vol.38 , pp. 3118-3120
    • de Silva, H.J.1    Dassanayake, A.S.2    Manamperi, A.3    de Silva, A.P.4
  • 37
    • 63249095067 scopus 로고    scopus 로고
    • Renal side effects of adefovir in hepatitis B virus-(HBV) positive kidney allograft recipients
    • [PMID: 19203548]
    • Kamar N, Huart A, Tack I, Alric L, Izopet J, Rostaing L. Renal side effects of adefovir in hepatitis B virus-(HBV) positive kidney allograft recipients. Clin Nephrol 2009; 71: 36-42 [PMID: 19203548]
    • (2009) Clin Nephrol , vol.71 , pp. 36-42
    • Kamar, N.1    Huart, A.2    Tack, I.3    Alric, L.4    Izopet, J.5    Rostaing, L.6
  • 38
    • 79958111465 scopus 로고    scopus 로고
    • Long-term add-on therapy with adefovir in lamivudine-resistant kidney graft recipients with chronic hepatitis B
    • [PMID:21486869]
    • Lampertico P, Viganò M, Facchetti F, Invernizzi F, Aroldi A, Lunghi G, Messa PG, Colombo M. Long-term add-on therapy with adefovir in lamivudine-resistant kidney graft recipients with chronic hepatitis B. Nephrol Dial Transplant 2011; 26: 2037-2041 [PMID:21486869 DOI: 10.1093/ndt/gfr174]
    • (2011) Nephrol Dial Transplant , vol.26 , pp. 2037-2041
    • Lampertico, P.1    Viganò, M.2    Facchetti, F.3    Invernizzi, F.4    Aroldi, A.5    Lunghi, G.6    Messa, P.G.7    Colombo, M.8
  • 39
    • 84865613156 scopus 로고    scopus 로고
    • Safety and efficacy of adefovir therapy for lamivudine-resistant hepatitis B virus infection in renal transplant recipients
    • [PMID: 22939662]
    • Lai HW, Chang CC, Chen TH, Tsai MC, Chen TY, Lin CC. Safety and efficacy of adefovir therapy for lamivudine-resistant hepatitis B virus infection in renal transplant recipients. J Formos Med Assoc 2012; 111: 439-444 [PMID: 22939662 DOI: 10.1016/j.jfma.2011.05.010]
    • (2012) J Formos Med Assoc , vol.111 , pp. 439-444
    • Lai, H.W.1    Chang, C.C.2    Chen, T.H.3    Tsai, M.C.4    Chen, T.Y.5    Lin, C.C.6
  • 40
    • 84892892578 scopus 로고    scopus 로고
    • Evolution of hepatitis B management in kidney transplantation
    • [PMID:24574715]
    • Yap DY, Chan TM. Evolution of hepatitis B management in kidney transplantation. World J Gastroenterol 2014; 20: 468-474 [PMID:24574715 DOI: 10.3748/wjg.v20.i2.468]
    • (2014) World J Gastroenterol , vol.20 , pp. 468-474
    • Yap, D.Y.1    Chan, T.M.2
  • 41
    • 84861661443 scopus 로고    scopus 로고
    • A novel experience of antiviral therapy for chronic hepatitis B in renal transplant recipients
    • [PMID: 22522918]
    • Hu TH, Tsai MC, Chien YS, Chen YT, Chen TC, Lin MT, Chang KC, Chiu KW. A novel experience of antiviral therapy for chronic hepatitis B in renal transplant recipients. Antivir Ther 2012; 17: 745-753 [PMID: 22522918 DOI: 10.3851/IMP2097]
    • (2012) Antivir Ther , vol.17 , pp. 745-753
    • Hu, T.H.1    Tsai, M.C.2    Chien, Y.S.3    Chen, Y.T.4    Chen, T.C.5    Lin, M.T.6    Chang, K.C.7    Chiu, K.W.8
  • 42
    • 52449119593 scopus 로고    scopus 로고
    • Entecavir therapy for adefovir-resistant hepatitis B virus infection in kidney and liver allograft recipients
    • [PMID:18724232]
    • Kamar N, Milioto O, Alric L, El Kahwaji L, Cointault O, Lavayssière L, Sauné K, Izopet J, Rostaing L. Entecavir therapy for adefovir-resistant hepatitis B virus infection in kidney and liver allograft recipients. Transplantation 2008; 86: 611-614 [PMID:18724232 DOI: 10.1097/TP.0b013e3181806c8c]
    • (2008) Transplantation , vol.86 , pp. 611-614
    • Kamar, N.1    Milioto, O.2    Alric, L.3    El Kahwaji, L.4    Cointault, O.5    Lavayssière, L.6    Sauné, K.7    Izopet, J.8    Rostaing, L.9
  • 43
    • 77957339492 scopus 로고    scopus 로고
    • Entecavir in the treatment of chronic hepatitis B in end stage renal disease and kidney transplantation
    • [DOI: 10.1002/dat.20485]
    • Ridruejo E, Adrover R, Alonso C, Mando OG, Silva MO. Entecavir in the treatment of chronic hepatitis B in end stage renal disease and kidney transplantation. Dial Transplant 2010; 39: 397-400 [DOI: 10.1002/dat.20485]
    • (2010) Dial Transplant , vol.39 , pp. 397-400
    • Ridruejo, E.1    Adrover, R.2    Alonso, C.3    Mando, O.G.4    Silva, M.O.5
  • 44
    • 84858701309 scopus 로고    scopus 로고
    • Entecavir in the treatment of chronic hepatitis B in kidney transplantation
    • author reply 999, [PMID: 22075262]
    • Ridruejo E, Adrover R, Mandó OG, Silva MO. Entecavir in the treatment of chronic hepatitis B in kidney transplantation. J Hepatol 2012; 56: 997-998; author reply 999 [PMID: 22075262 DOI: 10.1016/j.jhep.2011.09.019]
    • (2012) J Hepatol , vol.56 , pp. 997-998
    • Ridruejo, E.1    Adrover, R.2    Mandó, O.G.3    Silva, M.O.4
  • 46
    • 77952905778 scopus 로고    scopus 로고
    • Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B
    • [PMID: 19758269]
    • Tse KC, Yap DY, Tang CS, Yung S, Chan TM. Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B. Clin Transplant 2010; 24: 207-212 [PMID: 19758269 DOI: 10.1111/j.1399-0012.2009.01090.x]
    • (2010) Clin Transplant , vol.24 , pp. 207-212
    • Tse, K.C.1    Yap, D.Y.2    Tang, C.S.3    Yung, S.4    Chan, T.M.5
  • 47
    • 84885071926 scopus 로고    scopus 로고
    • Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?
    • [PMID: 24052632]
    • Tourret J, Deray G, Isnard-Bagnis C. Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword? J Am Soc Nephrol 2013; 24: 1519-1527 [PMID: 24052632 DOI: 10.1681/ASN.2012080857]
    • (2013) J Am Soc Nephrol , vol.24 , pp. 1519-1527
    • Tourret, J.1    Deray, G.2    Isnard-Bagnis, C.3
  • 49
    • 33845252959 scopus 로고    scopus 로고
    • Hepatitis B treatment: Lessons for the nephrologist
    • [PMID: 17021602]
    • Olsen SK, Brown RS. Hepatitis B treatment: Lessons for the nephrologist. Kidney Int 2006; 70: 1897-1904 [PMID: 17021602 DOI: 10.1038/sj.ki.5001908]
    • (2006) Kidney Int , vol.70 , pp. 1897-1904
    • Olsen, S.K.1    Brown, R.S.2
  • 50
    • 84901454701 scopus 로고    scopus 로고
    • Management of patients with hepatitis B and C before and after liver and kidney transplantation
    • [PMID: 24868325]
    • Pipili C, Cholongitas E. Management of patients with hepatitis B and C before and after liver and kidney transplantation. World J Hepatol 2014; 6: 315-325 [PMID: 24868325 DOI: 10.4254/wjh. v6.i5.315]
    • (2014) World J Hepatol , vol.6 , pp. 315-325
    • Pipili, C.1    Cholongitas, E.2
  • 51
    • 0035865376 scopus 로고    scopus 로고
    • Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence
    • [PMID: 11233898]
    • Han DJ, Kim TH, Park SK, Lee SK, Kim SB, Yang WS, Park JS, Jung JG, Yu ES, Kim SC. Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence. Transplantation 2001; 71: 387-394 [PMID: 11233898]
    • (2001) Transplantation , vol.71 , pp. 387-394
    • Han, D.J.1    Kim, T.H.2    Park, S.K.3    Lee, S.K.4    Kim, S.B.5    Yang, W.S.6    Park, J.S.7    Jung, J.G.8    Yu, E.S.9    Kim, S.C.10
  • 53
    • 0036829841 scopus 로고    scopus 로고
    • Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients
    • [PMID: 12395336]
    • Chan TM, Fang GX, Tang CS, Cheng IK, Lai KN, Ho SK. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients. Hepatology 2002; 36: 1246-1252 [PMID: 12395336 DOI: 10.1053/jhep.2002.36156]
    • (2002) Hepatology , vol.36 , pp. 1246-1252
    • Chan, T.M.1    Fang, G.X.2    Tang, C.S.3    Cheng, I.K.4    Lai, K.N.5    Ho, S.K.6
  • 54
    • 84878531340 scopus 로고    scopus 로고
    • Comparison of clinical outcomes in hepatitis B virus-positive kidney transplant recipients with or without pretransplantation antiviral therapy
    • [PMID: 23726576]
    • Kim HG, Kim EY, Yu YJ, Kim GH, Jeong JW, Byeon JH, Chung BH, Yang CW. Comparison of clinical outcomes in hepatitis B virus-positive kidney transplant recipients with or without pretransplantation antiviral therapy. Transplant Proc 2013; 45: 1374-1378 [PMID: 23726576 DOI: 10.1016/j.transproceed.2013.01. 088]
    • (2013) Transplant Proc , vol.45 , pp. 1374-1378
    • Kim, H.G.1    Kim, E.Y.2    Yu, Y.J.3    Kim, G.H.4    Jeong, J.W.5    Byeon, J.H.6    Chung, B.H.7    Yang, C.W.8
  • 55
    • 84867690859 scopus 로고    scopus 로고
    • Long-term impact of prophylactic antiviral treatment in Hepatitis B surface antigen positive renal allograft recipients
    • [PMID: 22541690]
    • Park KS, Yang WS, Han DJ, Park JB, Park JS, Park SK. Long-term impact of prophylactic antiviral treatment in Hepatitis B surface antigen positive renal allograft recipients. Clin Nephrol 2012; 78: 303-311 [PMID: 22541690 DOI: 10.5414/CN107617]
    • (2012) Clin Nephrol , vol.78 , pp. 303-311
    • Park, K.S.1    Yang, W.S.2    Han, D.J.3    Park, J.B.4    Park, J.S.5    Park, S.K.6
  • 56
    • 66149190943 scopus 로고    scopus 로고
    • Reactivation of hepatitis B
    • [PMID: 19399803]
    • Hoofnagle JH. Reactivation of hepatitis B. Hepatology 2009; 49: S156-S165 [PMID: 19399803 DOI: 10.1002/hep.22945]
    • (2009) Hepatology , vol.49 , pp. S156-S165
    • Hoofnagle, J.H.1
  • 58
    • 33644819694 scopus 로고    scopus 로고
    • HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies
    • [PMID:16303005]
    • Fabrizi F, Martin P, Dixit V, Kanwal F, Dulai G. HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005; 5: 2913-2921 [PMID:16303005 DOI: 10.1111/j.1600-6143.2005.01113.x]
    • (2005) Am J Transplant , vol.5 , pp. 2913-2921
    • Fabrizi, F.1    Martin, P.2    Dixit, V.3    Kanwal, F.4    Dulai, G.5
  • 59
    • 84903818820 scopus 로고    scopus 로고
    • Hepatitis B and survival after renal transplant: meta-analysis of observational studies
    • Fabrizi F, Dixit V, Martin P, Messa P. Hepatitis B and survival after renal transplant: meta-analysis of observational studies. J Viral Hepat 2014; 21: 542-550 [DOI: 10.1111/jvh.12184]
    • (2014) J Viral Hepat , vol.21 , pp. 542-550
    • Fabrizi, F.1    Dixit, V.2    Martin, P.3    Messa, P.4
  • 60
    • 84862641072 scopus 로고    scopus 로고
    • Benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection
    • [PMID:22414762]
    • Cosconea S, Fontaine H, Méritet JF, Corouge M, Sogni P, Vallet-Pichard A, Mallet V, Legendre C, Pol S. Benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection. J Hepatol 2012; 57: 55-60 [PMID:22414762 DOI: 10.1016/j.jhep.2012.02.020]
    • (2012) J Hepatol , vol.57 , pp. 55-60
    • Cosconea, S.1    Fontaine, H.2    Méritet, J.F.3    Corouge, M.4    Sogni, P.5    Vallet-Pichard, A.6    Mallet, V.7    Legendre, C.8    Pol, S.9
  • 61
    • 84880955388 scopus 로고    scopus 로고
    • Further evidence of the benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection
    • [PMID: 23207145]
    • Sperl J, Frankova S, Spicak J, Viklicky O. Further evidence of the benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection. J Hepatol 2013; 58: 833-835 [PMID: 23207145 DOI: 10.1016/j.jhep.2012.11.032]
    • (2013) J Hepatol , vol.58 , pp. 833-835
    • Sperl, J.1    Frankova, S.2    Spicak, J.3    Viklicky, O.4
  • 62
    • 84871553091 scopus 로고    scopus 로고
    • Long-term outcome of Hepatitis B-positive renal allograft recipients after development of antiviral treatment
    • [PMID:22541689]
    • Park KS, Han DJ, Park JB, Park JS, Park S. Long-term outcome of Hepatitis B-positive renal allograft recipients after development of antiviral treatment. Clin Nephrol 2012; 78: 391-398 [PMID:22541689 DOI: 10.5414/CN107565]
    • (2012) Clin Nephrol , vol.78 , pp. 391-398
    • Park, K.S.1    Han, D.J.2    Park, J.B.3    Park, J.S.4    Park, S.5
  • 63
    • 21844439208 scopus 로고    scopus 로고
    • Hepatocellular carcinoma in renal transplant patients
    • [PMID: 15964346]
    • Ridruejo E, Mandó OG, Dávalos M, Díaz C, Vilches A. Hepatocellular carcinoma in renal transplant patients. Transplant Proc 2005; 37: 2086-2088 [PMID: 15964346 DOI: 10.1016/j.transp roceed.2005.03.010]
    • (2005) Transplant Proc , vol.37 , pp. 2086-2088
    • Ridruejo, E.1    Mandó, O.G.2    Dávalos, M.3    Díaz, C.4    Vilches, A.5
  • 66
    • 84862881523 scopus 로고    scopus 로고
    • The therapeutic response of antiviral therapy in HBsAg-positive renal transplant recipients and a longterm follow-up
    • [PMID: 21744310]
    • Hu TH, Tsai MC, Chen YT, Chien YS, Hung CH, Chen TC, Tseng PL, Chang KC, Yen YH. The therapeutic response of antiviral therapy in HBsAg-positive renal transplant recipients and a longterm follow-up. Hepatol Int 2011; 16: [PMID: 21744310 DOI: 10.1007/s12072-011-9295-6]
    • (2011) Hepatol Int , vol.16
    • Hu, T.H.1    Tsai, M.C.2    Chen, Y.T.3    Chien, Y.S.4    Hung, C.H.5    Chen, T.C.6    Tseng, P.L.7    Chang, K.C.8    Yen, Y.H.9
  • 67
    • 66149190942 scopus 로고    scopus 로고
    • Side effects of long-term oral antiviral therapy for hepatitis B
    • [PMID: 19399802]
    • Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology 2009; 49: S185-S195 [PMID: 19399802 DOI: 10.1002/hep.22885]
    • (2009) Hepatology , vol.49 , pp. S185-S195
    • Fontana, R.J.1
  • 68
    • 84897603558 scopus 로고    scopus 로고
    • Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment
    • [PMID:24372662]
    • Fung J, Seto WK, Lai CL, Yuen MF. Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment. J Gastroenterol Hepatol 2014; 29: 428-434 [PMID:24372662 DOI: 10.1111/jgh.12499]
    • (2014) J Gastroenterol Hepatol , vol.29 , pp. 428-434
    • Fung, J.1    Seto, W.K.2    Lai, C.L.3    Yuen, M.F.4
  • 70
    • 84890612444 scopus 로고    scopus 로고
    • Potential benefit of telbivudine on renal function does not outweigh its high rate of antiviral drug resistance and other adverse effects
    • [PMID:24275236]
    • Yapali S, Lok AS. Potential benefit of telbivudine on renal function does not outweigh its high rate of antiviral drug resistance and other adverse effects. Gastroenterology 2014; 146: 15-19 [PMID:24275236 DOI: 10.1053/j.gastro.2013.11.028]
    • (2014) Gastroenterology , vol.146 , pp. 15-19
    • Yapali, S.1    Lok, A.S.2
  • 72
    • 84862957095 scopus 로고    scopus 로고
    • Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients
    • [PMID: 21777281]
    • Kim YJ, Cho HC, Sinn DH, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients. J Gastroenterol Hepatol 2012; 27: 306-312 [PMID: 21777281 DOI: 10.1111/j.1440-1746.2011.06852.x]
    • (2012) J Gastroenterol Hepatol , vol.27 , pp. 306-312
    • Kim, Y.J.1    Cho, H.C.2    Sinn, D.H.3    Gwak, G.Y.4    Choi, M.S.5    Koh, K.C.6    Paik, S.W.7    Yoo, B.C.8    Lee, J.H.9
  • 74
    • 80053938419 scopus 로고    scopus 로고
    • Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients
    • [PMID: 22093327]
    • Manolakopoulos S, Striki A, Deutsch M, Mela M, Ketikoglou I, Tzourmakliotis D, Manesis EK, Papatheodoridis GV. Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients. Liver Int 2011; 31: 1525-1532 [PMID: 22093327 DOI: 10.1111/j.1478-3231.2011.02616.x]
    • (2011) Liver Int , vol.31 , pp. 1525-1532
    • Manolakopoulos, S.1    Striki, A.2    Deutsch, M.3    Mela, M.4    Ketikoglou, I.5    Tzourmakliotis, D.6    Manesis, E.K.7    Papatheodoridis, G.V.8
  • 80
    • 84860139299 scopus 로고    scopus 로고
    • Prevalence of renal alterations indicative for proximal tubular damage (PTD) in patients with chronic hepatitis B virus (HBV) infection during long-term treatment with tenofovir disoproxil fumarate (TDF)
    • Brodzinski A, Fueloep B, Schlosser B, Biermer M, Wiegand J, Berg T, van Bommel F. Prevalence of renal alterations indicative for proximal tubular damage (PTD) in patients with chronic hepatitis B virus (HBV) infection during long-term treatment with tenofovir disoproxil fumarate (TDF). Hepatology 2010; 52 (Suppl 1): 515-6A
    • (2010) Hepatology , vol.52 , pp. 515A-5166A
    • Brodzinski, A.1    Fueloep, B.2    Schlosser, B.3    Biermer, M.4    Wiegand, J.5    Berg, T.6    van Bommel, F.7
  • 82
    • 84897596291 scopus 로고    scopus 로고
    • Do tenofovir and entecavir affect renal function in patients with chronic hepatitis B (CHB)? A two-year observational study from a single Australian centre
    • Le ST, Sahhar L, Lim J, He T, Ha P, Rusli F, Ratnam D, Moore GT, Pianko S, Dev A, Polkinghorne K, Sievert W. Do tenofovir and entecavir affect renal function in patients with chronic hepatitis B (CHB)? A two-year observational study from a single Australian centre. Hepatology 2012; 56 (Suppl 1): 410A
    • (2012) Hepatology , vol.56 , pp. 410A
    • Le, S.T.1    Sahhar, L.2    Lim, J.3    He, T.4    Ha, P.5    Rusli, F.6    Ratnam, D.7    Moore, G.T.8    Pianko, S.9    Dev, A.10    Polkinghorne, K.11    Sievert, W.12
  • 83
    • 84897659481 scopus 로고    scopus 로고
    • A single centre, large "real-life" cohort treated with tenofovir versus entecavir: no deterioration in renal function in tenofovir cohort over 12 months of therapy
    • Nguyen HL, Al-Freah MA, Joe D, Carey I, Boyer T, Suddle A, Harrison PM, Agarwal K. A single centre, large "real-life" cohort treated with tenofovir versus entecavir: no deterioration in renal function in tenofovir cohort over 12 months of therapy. Hepatology 2011; 54 (Suppl 1): 604A
    • (2011) Hepatology , vol.54 , pp. 604A
    • Nguyen, H.L.1    Al-Freah, M.A.2    Joe, D.3    Carey, I.4    Boyer, T.5    Suddle, A.6    Harrison, P.M.7    Agarwal, K.8
  • 84
    • 84864106252 scopus 로고    scopus 로고
    • Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B
    • quiz e68, [PMID: 22507876]
    • Gish RG, Clark MD, Kane SD, Shaw RE, Mangahas MF, Baqai S. Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B. Clin Gastroenterol Hepatol 2012; 10: 941-946; quiz e68 [PMID: 22507876 DOI: 10.1016/j.cgh.2012.04.008]
    • (2012) Clin Gastroenterol Hepatol , vol.10 , pp. 941-946
    • Gish, R.G.1    Clark, M.D.2    Kane, S.D.3    Shaw, R.E.4    Mangahas, M.F.5    Baqai, S.6
  • 85
    • 80053935254 scopus 로고    scopus 로고
    • Risk of renal toxicity with tenofovir DF (TDF) for chronic hepatitis B (CHB)
    • Gish R, Mangahas M, Baqai S, Shaw R. Risk of renal toxicity with tenofovir DF (TDF) for chronic hepatitis B (CHB). J Hepatol 2010; 52 (Suppl 1): S388-389 [DOI: 10.1016/S0168-8278(10)61008-2]
    • (2010) J Hepatol , vol.52 , pp. S388-S389
    • Gish, R.1    Mangahas, M.2    Baqai, S.3    Shaw, R.4
  • 86
    • 81355149665 scopus 로고    scopus 로고
    • Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B
    • [PMID: 21703180]
    • Mauss S, Berger F, Filmann N, Hueppe D, Henke J, Hegener P, Athmann C, Schmutz G, Herrmann E. Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B. J Hepatol 2011; 55: 1235-1240 [PMID: 21703180 DOI: 10.1016/j.jhep.2011.03.030]
    • (2011) J Hepatol , vol.55 , pp. 1235-1240
    • Mauss, S.1    Berger, F.2    Filmann, N.3    Hueppe, D.4    Henke, J.5    Hegener, P.6    Athmann, C.7    Schmutz, G.8    Herrmann, E.9
  • 87
    • 84860159427 scopus 로고    scopus 로고
    • Safety of long-term nucleos(t)ide treatment in chronic hepatitis B
    • [PMID: 22417072]
    • Ridruejo E, Silva MO. Safety of long-term nucleos(t)ide treatment in chronic hepatitis B. Expert Opin Drug Saf 2012; 11: 357-360 [PMID: 22417072 DOI: 10.1517/14740338.2012.672972]
    • (2012) Expert Opin Drug Saf , vol.11 , pp. 357-360
    • Ridruejo, E.1    Silva, M.O.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.